Late filing
Filing comparison
Protagenic Therapeutics, Inc.\new told the SEC it could not file its quarterly report on time
Does not expect a significant change in results.
(the “Company”) will not be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 by the prescribed due date without unreasonable effort or expense.
Evidence
- Anticipates significant change
- False
- Other periodic reports filed
- True
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- (the “Company”) will not be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 by the prescribed due date without unreasonable effort or expense.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.